Dariohealth Corp Stock Current Valuation
| DRIO Stock | USD 1.47 0.03 2.00% |
Valuation analysis of DarioHealth Corp helps investors to measure DarioHealth Corp's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of the 26th of April 2024, Enterprise Value Over EBITDA is likely to drop to -0.85. In addition to that, Enterprise Value Multiple is likely to drop to -0.85. Fundamental drivers impacting DarioHealth Corp's valuation include:
Price Book 0.6228 | Enterprise Value 35.4 M | Enterprise Value Ebitda (0.53) | Price Sales 1.7794 | Enterprise Value Revenue 1.4229 |
Undervalued
Today
Please note that DarioHealth Corp's price fluctuation is very risky at this time. Calculation of the real value of DarioHealth Corp is based on 3 months time horizon. Increasing DarioHealth Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for DarioHealth Corp is useful when determining the fair value of the DarioHealth stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of DarioHealth Corp. Since DarioHealth Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DarioHealth Stock. However, DarioHealth Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.47 | Real 3.04 | Target 7.82 | Hype 1.42 | Naive 1.46 |
The real value of DarioHealth Stock, also known as its intrinsic value, is the underlying worth of DarioHealth Corp Company, which is reflected in its stock price. It is based on DarioHealth Corp's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of DarioHealth Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence DarioHealth Corp's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of DarioHealth Corp helps investors to forecast how DarioHealth stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DarioHealth Corp more accurately as focusing exclusively on DarioHealth Corp's fundamentals will not take into account other important factors: DarioHealth Corp Company Current Valuation Analysis
DarioHealth Corp's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current DarioHealth Corp Current Valuation | 35.44 M |
Most of DarioHealth Corp's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DarioHealth Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
DarioHealth Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for DarioHealth Corp is extremely important. It helps to project a fair market value of DarioHealth Stock properly, considering its historical fundamentals such as Current Valuation. Since DarioHealth Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of DarioHealth Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of DarioHealth Corp's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, DarioHealth Corp has a Current Valuation of 35.44 M. This is 99.75% lower than that of the Health Care Equipment & Supplies sector and 99.55% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.79% higher than that of the company.
DarioHealth Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DarioHealth Corp's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DarioHealth Corp could also be used in its relative valuation, which is a method of valuing DarioHealth Corp by comparing valuation metrics of similar companies.DarioHealth Corp is currently under evaluation in current valuation category among related companies.
DarioHealth Corp Current Valuation Drivers
We derive many important indicators used in calculating different scores of DarioHealth Corp from analyzing DarioHealth Corp's financial statements. These drivers represent accounts that assess DarioHealth Corp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of DarioHealth Corp's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 14.9M | 85.2M | 215.2M | 101.2M | 48.8M | 37.0M | |
| Enterprise Value | (4.8M) | 57.2M | 179.7M | 79.8M | 41.3M | 27.6M |
DarioHealth Fundamentals
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.33 | ||||
| Profit Margin | (2.92) % | ||||
| Operating Margin | (3.90) % | ||||
| Current Valuation | 35.44 M | ||||
| Shares Outstanding | 29.68 M | ||||
| Shares Owned By Insiders | 14.81 % | ||||
| Shares Owned By Institutions | 29.43 % | ||||
| Number Of Shares Shorted | 1.38 M | ||||
| Price To Earning | (2.30) X | ||||
| Price To Book | 0.62 X | ||||
| Price To Sales | 1.78 X | ||||
| Revenue | 20.35 M | ||||
| Gross Profit | 14.01 M | ||||
| EBITDA | (50.84 M) | ||||
| Net Income | (54.86 M) | ||||
| Cash And Equivalents | 67.95 M | ||||
| Cash Per Share | 2.96 X | ||||
| Total Debt | 29.54 M | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 6.35 X | ||||
| Book Value Per Share | 2.14 X | ||||
| Cash Flow From Operations | (30.38 M) | ||||
| Short Ratio | 11.53 X | ||||
| Earnings Per Share | (1.93) X | ||||
| Target Price | 5.67 | ||||
| Number Of Employees | 276 | ||||
| Beta | 1.66 | ||||
| Market Capitalization | 44.51 M | ||||
| Total Asset | 96.39 M | ||||
| Retained Earnings | (349.36 M) | ||||
| Working Capital | 34.84 M | ||||
| Current Asset | 4.29 M | ||||
| Current Liabilities | 1.69 M | ||||
| Net Asset | 96.39 M |
About DarioHealth Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DarioHealth Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DarioHealth Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DarioHealth Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with DarioHealth Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DarioHealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will appreciate offsetting losses from the drop in the long position's value.Moving against DarioHealth Stock
| 0.76 | DSGN | Design Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.74 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.73 | AGTI | Agiliti Financial Report 14th of May 2024 | PairCorr |
| 0.7 | NXL | Nexalin Technology | PairCorr |
| 0.62 | VKTX | Viking Therapeutics Buyout Trend | PairCorr |
The ability to find closely correlated positions to DarioHealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DarioHealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DarioHealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DarioHealth Corp to buy it.
The correlation of DarioHealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DarioHealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DarioHealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DarioHealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out DarioHealth Corp Piotroski F Score and DarioHealth Corp Altman Z Score analysis. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for DarioHealth Stock analysis
When running DarioHealth Corp's price analysis, check to measure DarioHealth Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DarioHealth Corp is operating at the current time. Most of DarioHealth Corp's value examination focuses on studying past and present price action to predict the probability of DarioHealth Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DarioHealth Corp's price. Additionally, you may evaluate how the addition of DarioHealth Corp to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is DarioHealth Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.93) | Revenue Per Share 0.717 | Quarterly Revenue Growth (0.47) | Return On Assets (0.33) | Return On Equity (0.86) |
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.